TRCT
MPT

Tower Research Capital (TRC)’s Medical Properties Trust MPT Stock Holding History

Tower Research Capital (TRC)’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.4K Buy
7,852
+709
+10% +$3.7K ﹤0.01% 3020
2025
Q4 		$35.7K Sell
7,143
-4,707
-40% -$24.5K ﹤0.01% 2681
2025
Q3 		$60.1K Buy
11,850
+9,090
+329% +$40K ﹤0.01% 2377
2025
Q2 		$11.9K Buy
2,760
+34
+1% +$168 ﹤0.01% 3901
2025
Q1 		$16.4K Sell
2,726
-8,761
-76% -$44.3K ﹤0.01% 3163
2024
Q4 		$45.4K Sell
11,487
-14,389
-56% -$64.5K ﹤0.01% 2619
2024
Q3 		$151K Sell
25,876
-108,638
-81% -$536K ﹤0.01% 1884
2024
Q2 		$580K Sell
134,514
-76,792
-36% -$368K 0.01% 1213
2024
Q1 		$993K Buy
211,306
+145,764
+222% +$558K 0.02% 523
2023
Q4 		$322K Buy
65,542
+24,873
+61% +$122K ﹤0.01% 1722
2023
Q3 		$222K Sell
40,669
-32,654
-45% -$262K 0.01% 1365
2023
Q2 		$679K Sell
73,323
-25,228
-26% -$213K 0.02% 765
2023
Q1 		$810K Buy
98,551
+71,986
+271% +$795K 0.03% 548
2022
Q4 		$296K Sell
26,565
-23,985
-47% -$279K 0.01% 1028
2022
Q3 		$600K Sell
50,550
-31,736
-39% -$481K 0.01% 999
2022
Q2 		$1.26M Buy
82,286
+9,873
+14% +$178K 0.03% 571
2022
Q1 		$1.53M Buy
72,413
+27,751
+62% +$598K 0.01% 649
2021
Q4 		$1.05M Buy
44,662
+11,487
+35% +$246K 0.02% 671
2021
Q3 		$666K Sell
33,175
-53,788
-62% -$1.1M 0.02% 785
2021
Q2 		$1.75M Buy
86,963
+20,772
+31% +$444K 0.05% 358
2021
Q1 		$1.41M Buy
66,191
+22,182
+50% +$477K 0.02% 607
2020
Q4 		$959K Buy
44,009
+12,780
+41% +$249K 0.03% 543
2020
Q3 		$551K Sell
31,229
-33,757
-52% -$628K 0.01% 1575
2020
Q2 		$1.22M Buy
+64,986
New +$1.15M 0.05% 406
2020
Q1 		– Sell
-31
Closed -$1K – 3572
2019
Q4 		$1K Sell
31
-2,494
-99% -$50.5K ﹤0.01% 3285
2019
Q3 		$49K Sell
2,525
-3,474
-58% -$63.8K ﹤0.01% 1818
2019
Q2 		$104K Sell
5,999
-21,580
-78% -$389K 0.01% 1158
2019
Q1 		$510K Buy
27,579
+3,507
+15% +$62.5K 0.03% 592
2018
Q4 		$387K Buy
24,072
+7,902
+49% +$125K 0.03% 495
2018
Q3 		$241K Sell
16,170
-897
-5% -$13.1K 0.02% 869
2018
Q2 		$239K Sell
17,067
-17,580
-51% -$233K 0.01% 993
2018
Q1 		$450K Buy
34,647
+33,852
+4,258% +$433K 0.04% 526
2017
Q4 		$11K Buy
+795
New +$10.7K ﹤0.01% 2497
2017
Q2 		– Sell
-883
Closed -$11K – 3172
2017
Q1 		$11K Sell
883
-26,434
-97% -$338K ﹤0.01% 1699
2016
Q4 		$336K Buy
27,317
+19,851
+266% +$257K 0.04% 465
2016
Q3 		$111K Sell
7,466
-19,187
-72% -$290K 0.01% 763
2016
Q2 		$405K Buy
26,653
+25,953
+3,708% +$367K 0.04% 329
2016
Q1 		$9K Sell
700
-700
-50% -$7.98K ﹤0.01% 2069
2015
Q4 		$16K Buy
+1,400
New +$16K ﹤0.01% 1540
2015
Q2 		– Sell
-21,549
Closed -$318K – 4795
2015
Q1 		$318K Buy
21,549
+21,084
+4,534% +$313K 0.04% 243
2014
Q4 		$6K Sell
465
-7,206
-94% -$96.5K ﹤0.01% 2593
2014
Q3 		$94K Buy
7,671
+6,971
+996% +$92.7K 0.01% 1030
2014
Q2 		$9K Sell
700
-3,041
-81% -$40.4K ﹤0.01% 2444
2014
Q1 		$48K Buy
3,741
+2,077
+125% +$26.7K 0.01% 1119
2013
Q4 		$20K Sell
1,664
-9,803
-85% -$125K ﹤0.01% 2335
2013
Q3 		$139K Buy
11,467
+10,509
+1,097% +$140K 0.02% 1017
2013
Q2 		$14K Buy
+958
New +$15.1K ﹤0.01% 2047

Other funds holding MPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Tower Research Capital (TRC)'s MPT Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Medical Properties Trust (MPT) stake by 9.9% in Q1 2026, buying an estimated $3.7K and bringing the position to 7,852 shares worth $36.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3020.

Tower Research Capital (TRC) first reported a position in MPT in Q2 2013 and has held it in 47 quarters since. The position peaked at $1.75M in Q2 2021. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Tower Research Capital (TRC) held 7,852 shares of Medical Properties Trust worth $36.4K as of Q1 2026.
  • Tower Research Capital (TRC) bought 709 Medical Properties Trust shares in Q1 2026, an estimated $3.7K.
  • Medical Properties Trust made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3020 holding.
  • Tower Research Capital (TRC) first reported a position in Medical Properties Trust in Q2 2013 and has held it in 47 quarters since.
  • Tower Research Capital (TRC)'s Medical Properties Trust position peaked at $1.75M in Q2 2021.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.